• Most Popular
  • Most Shared

Oman's Raysut Cement Q3 profit rises 22.9 percent

Sun Oct 25, 2009 1:19am EDT

DUBAI, Oct 25 (Reuters) - Oman's Raysut Cement RAYC.OM on Sunday posted a third-quarter net profit of 6.88 million rials ($16.44 million), up 22.9 percent from the same quarter last year.

Basic Materials

The company made a net profit of 24.18 million rials in the first nine months of the year, without offering a breakdown of quarterly data. That compared to 26.13 million rials in the prior-year period, it said in a statement on the Muscat bourse website.

It made a net profit of 5.6 million rials in the third quarter of 2008.

Analysts polled in a Reuters survey in October forecast an average 58 percent rise in third-quarter net profit. [ID:nL4507586]

(Reporting by Jason Benham; Editing by Amran Abocar)

Basic Materials


More from Reuters

Pro Life Democrat Rep. Bart Stupak holds an Executive Order from U.S. President Barack Obama claiming no money from passage of the health care bill will be used for abortion while on Capitol Hill in Washington, March 21, 2010. At left is Rep. Kathleen Dahlkemper (D-Pa). REUTERS/Larry Downing

Healthcare overhaul headed for passage

House Democrats neared passage of a healthcare bill that would create the biggest policy changes in decades and hand President Obama a landmark victory.  Full Article | Video 

Healthcare reform
A soldier guards hundreds of bags of wheat seed in the isolated district of Nad Ali's district centre in the west of Helmand province, October 17, 2009

Dirty money and Afghan war

As the war in Afghanistan enters its ninth year, the U.S. has finally realized the best way to stop the conflict is to cut the flow of drug money, columnist Bernd Debusmann writes.   Commentary 

    Afghanistan
    An H1N1 flu vaccine inoculation is given at the Geisinger Medical Center in Danville, Pennsylvania October 28, 2009. REUTERS/Brad Bower

    A new stab at conquering pain

    Millions of people worldwide suffer chronic pain that can last weeks, months or years but relief may be on the way.  Full Article 

      Pharmaceuticals